Literature DB >> 10674268

Expression of the plasminogen activator system and the inhibitors PAI-1 and PAI-2 in posttraumatic lesions of the CNS and brain injuries following dramatic circulatory arrests: an immunohistochemical study.

K Dietzmann1, P von Bossanyi, D Krause, H Wittig, C Mawrin, E Kirches.   

Abstract

Plasminogen activators as inducible extracellular serine proteases are involved in a variety of processes, such as the degradation of brain structures. In regions of brain degradation, an increase in the expression of genes encoding cytokines and proteinases has recently been demonstrated. We tested the hypothesis, whether the plasminogen activator system as well as the plasminogen activator inhibitors are expressed and possibly involved in a proteolytic cascade that breaks down the extracellular matrix as a result of ischemic or posttraumatic brain destructions. To study this supposition, we investigated immunohistochemically the expression of tPA, uPA and its receptor, the plasminogen activator inhibitors PAI-1 and PAI-2, tetranectin as well as the laminin breakdown as an event of secondary brain injury. Brain tissue from 21 autopsy cases with severe brain injuries, material from 14 ischemic infarcts and 11 controls with acute hypoxia were used. All components of the plasminogen activator system studied were over-expressed immunohistochemically in reactive astrocytes, microglia and endothelial cells around the lesion zone. Tetranectin showed an analogous distribution to the plasminogen activator system. A reduced immunoreactivity of laminin within the identical region of destruction was detected concomitant with laminin remnants in perivascular macrophages, so that a remarkable role of the plasmin cascade in the degradation of extracellular matrix proteins in the brain is taken into consideration.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10674268     DOI: 10.1016/s0344-0338(00)80017-5

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  10 in total

1.  FGF-2 regulates neurogenesis and degeneration in the dentate gyrus after traumatic brain injury in mice.

Authors:  Shinichi Yoshimura; Tetsuyuki Teramoto; Michael J Whalen; Michael C Irizarry; Yasushi Takagi; Jianhua Qiu; Jun Harada; Christian Waeber; Xandra O Breakefield; Michael A Moskowitz
Journal:  J Clin Invest       Date:  2003-10       Impact factor: 14.808

2.  Role of plasminogen activator inhibitor-1 in the diagnosis and prognosis of patients with Parkinson's disease.

Authors:  Hong Pan; Ying Zhao; Zhengping Zhai; Jinyu Zheng; Yong Zhou; Qijin Zhai; Xiangyang Cao; Jisha Tian; Liandong Zhao
Journal:  Exp Ther Med       Date:  2018-04-17       Impact factor: 2.447

3.  The tissue-type plasminogen activator-plasminogen activator inhibitor 1 complex promotes neurovascular injury in brain trauma: evidence from mice and humans.

Authors:  Maithili Sashindranath; Eunice Sales; Maria Daglas; Roxann Freeman; Andre L Samson; Elisa J Cops; Simone Beckham; Adam Galle; Catriona McLean; Cristina Morganti-Kossmann; Jeffrey V Rosenfeld; Rime Madani; Jean-Dominique Vassalli; Enming J Su; Daniel A Lawrence; Robert L Medcalf
Journal:  Brain       Date:  2012-07-20       Impact factor: 13.501

4.  Transcriptional activation of endothelial cells by TGFβ coincides with acute microvascular plasticity following focal spinal cord ischaemia/reperfusion injury.

Authors:  Richard L Benton; Melissa A Maddie; Toros A Dincman; Theo Hagg; Scott R Whittemore
Journal:  ASN Neuro       Date:  2009-08-26       Impact factor: 4.146

5.  Comprehensive gene expression profiling reveals synergistic functional networks in cerebral vessels after hypertension or hypercholesterolemia.

Authors:  Wei-Yi Ong; Mary Pei-Ern Ng; Sau-Yeen Loke; Shalai Jin; Ya-Jun Wu; Kazuhiro Tanaka; Peter Tsun-Hon Wong
Journal:  PLoS One       Date:  2013-07-16       Impact factor: 3.240

6.  Transcriptomic screening of microvascular endothelial cells implicates novel molecular regulators of vascular dysfunction after spinal cord injury.

Authors:  Richard L Benton; Melissa A Maddie; Christopher A Worth; Edward T Mahoney; Theo Hagg; Scott R Whittemore
Journal:  J Cereb Blood Flow Metab       Date:  2008-07-09       Impact factor: 6.200

7.  The Role of TLR4 and Fyn Interaction on Lipopolysaccharide-Stimulated PAI-1 Expression in Astrocytes.

Authors:  Hyun Myung Ko; Sung Hoon Lee; Ki Chan Kim; So Hyun Joo; Wahn Soo Choi; Chan Young Shin
Journal:  Mol Neurobiol       Date:  2014-08-09       Impact factor: 5.590

8.  Mechanism of plasminogen activator inhibitor-1 regulation by oncostatin M and interleukin-1 in human astrocytes.

Authors:  Aneta Kasza; Daniel L Kiss; Sunita Gopalan; Weili Xu; Russell E Rydel; Aleksander Koj; Tomasz Kordula
Journal:  J Neurochem       Date:  2002-11       Impact factor: 5.372

Review 9.  Serine Proteases and Chemokines in Neurotrauma: New Targets for Immune Modulating Therapeutics in Spinal Cord Injury.

Authors:  Roxana N Beladi; Kyle S Varkoly; Lauren Schutz; Liqiang Zhang; Jordan R Yaron; Qiuyun Guo; Michelle Burgin; Ian Hogue; Wesley Tierney; Wojciech Dobrowski; Alexandra R Lucas
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.708

10.  Plasminogen activator inhibitor-1 augments damage by impairing fibrinolysis after traumatic brain injury.

Authors:  Eva-Verena Griemert; Susanne M Schwarzmaier; Regina Hummel; Christina Gölz; Dong Yang; Winfried Neuhaus; Malgorzata Burek; Carola Y Förster; Ivan Petkovic; Raimund Trabold; Nikolaus Plesnila; Kristin Engelhard; Michael K Schäfer; Serge C Thal
Journal:  Ann Neurol       Date:  2019-03-30       Impact factor: 10.422

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.